Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 246 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Calcification Clear all

Conditions: Revision, Joint
Interventions: Trabecular Metal Revision Cup, Trabecular Metal Modular Cup; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Osteoporosis
Interventions: Fructooligosaccharide; Dietary Supplement
Lead sponsor: Purdue University; Other
Eligibility: 10 Years to 12 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Postmenopausal
Interventions: risedronate, experimental; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 50 Years to 85 Years · Female only
Enrollment: 370 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 4
States / cities: Daytona Beach, Florida • Gainesville, Florida • Shawnee Mission, Kansas + 1 more

Conditions: Vitamin D Deficiency
Interventions: Tri-Vi-Sol; Dietary Supplement
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 2 Hours
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Houston, Texas

Conditions: Renal Osteodystrophy
Interventions: doxercalciferol, Cholecalciferol; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 82 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Osteoporosis
Interventions: Behavioral modification - nutrition education; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 7 Years to 10 Years
Enrollment: 139 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2005
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoporosis
Interventions: LY2541546, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years to 85 Years · Female only
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Gainesville, Georgia • Bethesda, Maryland

Conditions: Vascular Calcification, Atherosclerosis, Bone Density
Interventions: CT of the bones; Procedure
Lead sponsor: University of Michigan; Other
Eligibility: 30 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Endometrial Cancer, Breast Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 15,595 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Effect of Treatment on Bone Mineral Density
Interventions: enclomiphene citrate, Placebo; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 17
States / cities: Mesa, Arizona • Phoenix, Arizona • Tempe, Arizona + 14 more

Conditions: Prostate Cancer, Osteoporosis, Hypogonadism
Interventions: alendronate; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 50 Years to 85 Years · Male only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Salmeterol 50 mcg BID, Fluticasone Propionate/Salmeterol 250/50 mcg BID, DISKUS inhaler; Drug · Device
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 37
States / cities: Berkeley, California • Fullerton, California • Rancho Mirage, California + 31 more

Conditions: HIV Infection, Alcohol Use, Bone Disease, Substance-Related Disorders
Interventions: Not listed
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Endometriosis
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 40 Years to 50 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Osteoporosis
Interventions: Raloxifene, Zoledronic acid, Placebo oral pills, Placebo intravenous (i.v.) infusion; Drug
Lead sponsor: Novartis; Industry
Eligibility: 45 Years to 80 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 17
States / cities: Phoenix, Arizona • Buena Park, California • Washington D.C., District of Columbia + 12 more

Conditions: Eosinophilic Esophagitis
Interventions: Bone Mineral Density (DEXA) scan, Vitamin D Measurement, Height measurement, Assessment of medication compliance; Diagnostic Test · Other
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 5 Years to 12 Years
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Postmenopausal, Osteopenia, Rheumatoid Arthritis, Osteoporosis
Interventions: Etanercept, Denosumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 45 Years to 80 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Duncansville, Pennsylvania • Dallas, Texas

Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder
Interventions: Dietary Phosphorus Intake; Dietary Supplement
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Osteoporosis
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 65 Years and older
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hyperparathyroidism, Secondary
Interventions: Etelcalcetide; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 40
States / cities: Alhambra, California • Azusa, California • Bakersfield, California + 37 more

Conditions: Breast Cancer, Osteoporosis
Interventions: Bone Mineral Density; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 3
States / cities: Basking Ridge, New Jersey • Commack, New York • New York, New York

Conditions: Breast Cancer, Bone Diseases
Interventions: Vitamin D; Drug
Lead sponsor: Mark Pegram; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Osteoporosis
Interventions: Lagenbone; Dietary Supplement
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 40 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Whittier, California

Conditions: Spinal Cord Injury, Spinal Cord Injuries, Injuries, Spinal Cord, Spinal Cord Contusion, Spinal Cord Trauma, Trauma, Nervous System, Wounds and Injuries, Spinal Cord Compression, Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male
Interventions: testosterone cypionate, finasteride, placebo injection, placebo pill; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 4
States / cities: Aurora, Colorado • Gainesville, Florida • Tampa, Florida + 1 more

Search by objective public record fields.

Evaluation of the Trabecular Metal™ Revision Hip Cup Using Bone Mineral Density (DEXA)

Fructooligosaccharide and Calcium Absorption in Adolescent Girls

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

Impact of Vitamin D Status on Bones in Breastfed Infants

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

Building Better Bones in Children

A Study of LY2541546 in Women With Low Bone Mineral Density

Association of Bone Quality and Quantity With Vascular Calcification

Bone Mineral Density and Subsequent Cancer Risk

Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism

Prevention of Osteoporosis in Men With Prostate Cancer

Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.

Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort

Effects of Endometriosis on Bone Mineral Density

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis

Effects of Denosumab on the Pharmacokinetics of Etanercept

Phosphate Assessment in Chronic Kidney Disease Patients Study

Does Gender Play a Role in Bone-mineral Density Measurement Precision?

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Effects of Lagenbone on Bone Mineral Density

Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial